로딩 중…
지수 로딩 중…
WHANIN PHARM CO.,LTD
016580· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩10,140-1.55%
2026-06-19
Price Chart
WHANIN PHARM CO.,LTD-15.08%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 188.60B KRW |
| Revenue | 266.19B KRW |
| Net Income | 4.36B KRW |
| Total Assets | 481.97B KRW |
| Net Assets | 424.14B KRW |
| Employees | 653 |
| Value | |
| P/E | 43.28x |
| P/B | 0.44x |
| PEG | 0.94x |
| P/S | 0.71x |
| EV/EBITDA | 23.67x |
| FCF Yield | 4.08% |
| Profitability | |
| ROE | 1.03% |
| ROA | 0.90% |
| Op. Margin | 2.10% |
| Revenue Growth | 18.23% |
| Earnings Growth | 45.82% |
| Financial Health | |
| Debt Ratio | 113.64% |
| Total Debt | 2.01B KRW |
| FCF | 7.69B KRW |
| Cash | 58.43B KRW |
| Current Ratio | 4.10x |
| Net Debt/EBITDA | -10.10x |
| Dividend | |
| Div. Yield | 2.91% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -15.08% |
| 1M Return | -6.37% |
| From 52W High | -23.24% |
| 1Y MDD | -23.69% |
| Trading | |
| Volume | 121,378 shares |
| Foreign Own. | 11.08% |
| Per Share | |
| EPS | 857 KRW |
| BPS | 22,947 KRW |
Company Info
Established in 1978 and listed on the securities market in 1996, Whanin Pharmaceutical is a pharmaceutical manufacturing and sales company specializing in psychoneurotic agents. Based on 2024 IMS DATA, it holds the leading market share in the domestic psychotherapeutic drug market. With a robust drug lineup and strong network, the company boasts significant sales strengths in the psychoneurotic field and is growing with the market due to increasing prescriptions driven by the rise in mental health-related medical institutions and patient visits.